The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Activity and safety of Nab-FOLFIRI and Nab-FOLFOX as first-line treatment for metastatic pancreatic cancer (phase II NabucCO study).
 
Elisa Giommoni
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene; Merck Serono
 
Evaristo Maiello
Consulting or Advisory Role - Lilly; Merck Serono; Roche/Genentech
Travel, Accommodations, Expenses - Merck Serono; Sanofi
 
Vanja Vaccaro
No Relationships to Disclose
 
Ermanno Rondini
No Relationships to Disclose
 
Caterina Vivaldi
No Relationships to Disclose
 
Giampaolo Tortora
Consulting or Advisory Role - Celgene; Merck Serono
Travel, Accommodations, Expenses - Merck Serono; Roche
 
Laura Toppo
No Relationships to Disclose
 
Guido Giordano
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Travel, Accommodations, Expenses - Celgene
 
Tiziana Pia Latiano
No Relationships to Disclose
 
Lorenzo Antonuzzo
Consulting or Advisory Role - Lilly; Roche/Genentech
Research Funding - Novartis
Travel, Accommodations, Expenses - Novartis; SERVIER
 
Cinzia Lamperini
No Relationships to Disclose
 
Luca Boni
No Relationships to Disclose
 
Francesco Di Costanzo
Consulting or Advisory Role - Celgene; Lilly; Merck Serono; Roche/Genentech; SERVIER
Research Funding - Celgene
Travel, Accommodations, Expenses - Merck Serono; Roche/Genentech; SERVIER